15h
Medpage Today on MSNSGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney DiseaseThe dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
Nate Robinson, the 11-year NBA veteran who won the league's Slam Dunk Contest three times, revealed on Instagram that he had ...
"Heart failure and kidney failure often go hand in hand," he told Newsweek, adding that the kidneys control the way the body handles salt and water. If they are not getting rid of these substances ...
She was diagnosed with a genetic kidney disease called reflux nephropathy which later progressed to kidney failure. "That was ...
More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...
Our study thus confirmed what was found in people of African descent in the US: the genetic origin underpinning the excess ...
Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...
Nearly all children with ANCA-associated vasculitis demonstrate active kidney disease at diagnosis, and their renal function ...
Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...
Kidney disease is a growing health concern in Australia, with many people unaware that they are affected. According to ...
Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map' of kidney function to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results